Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wumei Formula Granules is a Traditional Chinese Medicine (TCM) herbal preparation developed for the treatment of insomnia disorder, specifically targeting the Jueyin syndrome pattern. The formula is based on the classic Wumei Wan composition, which typically includes *Fructus Mume* (Wumei) as the primary ingredient alongside other botanical components. It is currently being evaluated by the Second Affiliated Hospital of Dalian Medical University in clinical trials to assess its efficacy in improving sleep quality and mood scales. The drug's mechanism is thought to involve the modulation of the hypothalamic-pituitary-adrenal (HPA) axis and the regulation of blood neurotransmitter levels, which are often dysregulated in chronic insomnia patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wumei Formula Granules.